Literature DB >> 2681214

Distribution of adenosine deaminase-complexing protein in murine tissues.

W N Dinjens1, J ten Kate, J T Wijnen, E P van der Linden, C J Beek, M H Lenders, P M Khan, F T Bosman.   

Abstract

It has been suggested that mouse and rat lack adenosine deaminase-complexing protein because in these species exclusively the small molecular weight form of adenosine deaminase (ADA-S) is found. This suggestion is based on the assumption that the adenosine deaminase binding capacity is an inherent functional characteristic of adenosine deaminase-complexing protein. We report on the presence of adenosine deaminase-complexing protein immunoreactivity in mouse and rat determined with a species cross-reactive polyclonal anti-adenosine deaminase-complexing protein serum. In the mouse the tissue and subcellular distribution and the electrophoretic mobility in starch and polyacrylamide gels of the protein correspond with those of adenosine deaminase-complexing protein, but it does not bind the small molecular weight form of adenosine deaminase. Furthermore, in human, mouse, and rat kidney cortex adenosine deaminase and adenosine deaminase-complexing protein did not colocalize by immunohistochemistry. It is suggested that the function of adenosine deaminase-complexing protein is not adenosine deaminase-related.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.

Authors:  Jixin Zhong; Andrei Maiseyeu; Stephen N Davis; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

2.  Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26.

Authors:  Holger K Eltzschig; Marion Faigle; Simone Knapp; Jorn Karhausen; Juan Ibla; Peter Rosenberger; Kirsten C Odegard; Peter C Laussen; Linda F Thompson; Sean P Colgan
Journal:  Blood       Date:  2006-05-02       Impact factor: 22.113

Review 3.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

4.  The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.

Authors:  Michael Engel; Torsten Hoffmann; Leona Wagner; Michael Wermann; Ulrich Heiser; Reiner Kiefersauer; Robert Huber; Wolfram Bode; Hans-Ulrich Demuth; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-10       Impact factor: 11.205

Review 5.  Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4.

Authors:  A Casrouge; A V Sauer; R Barreira da Silva; M Tejera-Alhambra; S Sánchez-Ramón; C Cancrini; M A Ingersoll; A Aiuti; M L Albert
Journal:  Clin Exp Immunol       Date:  2018-09-24       Impact factor: 4.330

6.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

Review 7.  The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.

Authors:  Guranda Chitadze; Ulrike Wehkamp; Ottmar Janssen; Monika Brüggemann; Marcus Lettau
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

8.  Gene expression profiles in developing nephrons using Lim1 metanephric mesenchyme-specific conditional mutant mice.

Authors:  You-Tzung Chen; Akio Kobayashi; Kin Ming Kwan; Randy L Johnson; Richard R Behringer
Journal:  BMC Nephrol       Date:  2006-02-07       Impact factor: 2.388

9.  Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts.

Authors:  D P Witte; D A Wiginton; J J Hutton; B J Aronow
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

10.  Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.

Authors:  Minyoung Lee; Eugene Shin; Jaehyun Bae; Yongin Cho; Ji-Yeon Lee; Yong-Ho Lee; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.